ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,420.63
0.13%
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs Yen
156.7275
0.02%
Brent Oil
79.395
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Reneo Pharmaceuticals Inc (RPHM)

  7. Reneo Pharmaceuticals Inc (RPHM) ニュース

RPHM

Reneo Pharmaceuticals (RPHM)

Reneo Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:RPHM
日付受信時刻ニュースソース見出しコード企業名
2024/05/1322 : 38Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RPHMReneo Pharmaceuticals Inc
2024/05/1322 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
2024/05/1320 : 35GlobeNewswire Inc.Reneo Pharmaceuticals and OnKure Announce Proposed MergerNASDAQ:RPHMReneo Pharmaceuticals Inc
2024/05/0805 : 03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPHMReneo Pharmaceuticals Inc
2024/05/0805 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
2024/05/0720 : 35GlobeNewswire Inc.Reneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
2024/03/2820 : 35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business UpdateNASDAQ:RPHMReneo Pharmaceuticals Inc
2024/03/2520 : 00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:RPHMReneo Pharmaceuticals Inc
2024/02/2406 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
2024/02/0606 : 01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/12/1423 : 26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/12/1423 : 05GlobeNewswire Inc.Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
2023/11/2214 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/11/1407 : 08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RPHMReneo Pharmaceuticals Inc
2023/11/1406 : 58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RPHMReneo Pharmaceuticals Inc
2023/11/1406 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPHMReneo Pharmaceuticals Inc
2023/11/1406 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/11/1321 : 35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/11/0220 : 50GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/10/3105 : 47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/10/2520 : 50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific MeetingsNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/10/0920 : 50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
2023/10/0621 : 30GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro SummitNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/08/3006 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/08/2920 : 35GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/08/2906 : 33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/08/1105 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/08/1020 : 35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/06/3021 : 25GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics ForumNASDAQ:RPHMReneo Pharmaceuticals Inc
2023/06/2621 : 25GlobeNewswire Inc.Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® IndicesNASDAQ:RPHMReneo Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RPHM

最近閲覧した銘柄

NASDAQ
AAPL
Apple
COIN
SOLUSD
Solana
NYSE
XOM
Exxon Mobil
FX
USDJPY
US Dollar vs Yen
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
SILVER
SILVER
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
MSFT
Microsoft
CCOM
US30
US 30
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
CCOM
US100
US Tech 100
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有